Product NDC: | 0054-0021 |
Proprietary Name: | Lithium Carbonate |
Non Proprietary Name: | Lithium Carbonate |
Active Ingredient(s): | 300 mg/1 & nbsp; Lithium Carbonate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0054-0021 |
Labeler Name: | Roxane Laboratories, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076832 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041028 |
Package NDC: | 0054-0021-25 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0054-0021-25) |
NDC Code | 0054-0021-25 |
Proprietary Name | Lithium Carbonate |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0054-0021-25) |
Product NDC | 0054-0021 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lithium Carbonate |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20041028 |
Marketing Category Name | ANDA |
Labeler Name | Roxane Laboratories, Inc |
Substance Name | LITHIUM CARBONATE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Mood Stabilizer [EPC] |